https://drugnews.com.tw/articles/2026-08-05-alnylam-amvuttra-ttr-growth-reset-en.html Drugnews｜藥時事 en 2026-08-05T00:00:00.000Z More Than $1 Billion in One Quarter: Why Did Alnylam Plunge 28%? https://drugnews.com.tw/articles/2026-08-05-alnylam-amvuttra-ttr-growth-reset.html Drugnews｜藥時事 zh-tw 2026-08-05T00:00:00.000Z 一季賣破 10 億，Alnylam 為何崩 28%？ https://drugnews.com.tw/articles/2026-08-04-astrazeneca-bms-400b-merger-talks-en.html Drugnews｜藥時事 en 2026-08-04T00:00:00.000Z A $400 Billion Pharma Merger? AstraZeneca and Bristol Myers Squibb Are Reportedly Talking https://drugnews.com.tw/articles/2026-08-04-astrazeneca-bms-400b-merger-talks.html Drugnews｜藥時事 zh-tw 2026-08-04T00:00:00.000Z 超級大藥廠 4,000 億美元合併？阿斯特捷利康＋BMS！